SciELO - Scientific Electronic Library Online

 
vol.34 número2Análise do perfil de vulnerabilidade da coinfecção de tuberculose em pessoas vivendo com HIVSérie temporal de mortalidade por avc da população adulta residente no estado do amazonas de 2000 a 2021 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

artigo

Indicadores

Compartilhar


Journal of Human Growth and Development

versão impressa ISSN 0104-1282versão On-line ISSN 2175-3598

J. Hum. Growth Dev. vol.34 no.2 Santo André maio/ago. 2024  Epub 10-Fev-2025

https://doi.org/10.36311/jhgd.v34.14098 

ORIGINAL ARTICLE

Factors associated with abandonment of tuberculosis treatment: a cross-sectional study between 2014 and 2019

João Paulo Cola, All authors contributed to the manuscript, contributed to the conception and design of the study, analysis, and interpretation of the results, writing and critical review of the content of the manuscripta  b 
http://orcid.org/0000-0003-4972-4686

Sindy Azevedo Pinto, All authors contributed to the manuscript, contributed to the conception and design of the study, analysis, and interpretation of the results, writing and critical review of the content of the manuscriptb 
http://orcid.org/0000-0001-5918-0892

Jhenniffer Santos de Souza, All authors contributed to the manuscript, contributed to the conception and design of the study, analysis, and interpretation of the results, writing and critical review of the content of the manuscriptb 
http://orcid.org/0000-0002-1197-0542

Juliana Ferreira Hertel, All authors contributed to the manuscript, contributed to the conception and design of the study, analysis, and interpretation of the results, writing and critical review of the content of the manuscriptb 
http://orcid.org/0000-0002-7756-9778

Heletícia Scabelo Galavote, All authors contributed to the manuscript, contributed to the interpretation of the results, writing, and critical review of the content of the manuscriptc 
http://orcid.org/0000-0003-4490-6763

Thiago Nascimento do Prado, All authors contributed to the manuscript, contributed to the conception and design of the study, analysis, and interpretation of the results, writing and critical review of the content of the manuscripta 
http://orcid.org/0000-0001-8132-6288

Ethel Leonor Noia Maciel, All authors contributed to the manuscript, contributed to the interpretation of the results, writing and critical review of the content of the manuscripta 
http://orcid.org/0000-0003-4826-3355

aPostgraduate Program in Collective Health, Universidade Federal do Espírito Santo, Vitória, Brazil;

bColegiado do Curso de Enfermagem, Faculdade MULTIVIX São Mateus, São Mateus, Brazil;

cCentro Universitário Norte do Espírito Santo, Universidade Federal do Espírito Santo, São Mateus, Brazil.


ABSTRACT

Authors summary

Why was this study done?

Tuberculosis is one of the world’s leading infectious and deadly diseases. Brazil has not yet achieved the goals set by the World Health Organization for the control and eradication of the disease. Abandonment of tuberculosis treatment may contribute to the spread and maintenance of the chain of disease transmission. Thus, this study aimed to analyze the factors associated with abandonment of tuberculosis treatment to contribute to formulating strategies for reducing abandonment and controlling the disease.

What did the researchers do and find?

A cross-sectional study was conducted with individuals diagnosed with tuberculosis in Brazil between 2014 and 2019, reported in the Notifiable Diseases Information System (Sistema de Informação de Agravos de Notificação - SINAN). Factors associated with the abandonment of tuberculosis treatment were assessed. There was a prevalence of 16.4% of patients who resumed treatment. The prevalence of abandonment was higher among homeless individuals, black ethnicity/skin color, people living with HIV, alcoholics, illicit drug use, and individuals who re-entered treatment after abandoning it. Individuals who underwent the directly observed treatment had the lowest prevalence of the abandonment of tuberculosis treatment.

What do these findings mean?

Social and economic vulnerability is present among individuals affected by tuberculosis and is associated with abandonment of treatment. Therefore, it is necessary to implement educational strategies in health, to implement street clinics with a greater focus on tuberculosis treatment, and to increase the supply of directly observed treatment to reduce ATT.

Key words: tuberculosis; abandonment of tuberculosis treatment; social vulnerability; cross-sectional studies

Abstract

Introduction

tuberculosis (TB) is a public health problem. Brazil is among the group of 22 countries responsible for 90% of the world’s TB cases. High proportions of abandonment of treatment may contribute to this epidemiological scenario that is difficult to control.

Objective

to analyze the factors associated with abandonment of tuberculosis treatment (ATT).Methods: this is a cross-sectional study of individuals diagnosed with tuberculosis in Brazil between 2014 and 2019 whose cases had been reported to the Notifiable Diseases Information System. Poisson regression of robust variance was used according to hierarchical levels.

Results

a total of 508,787 cases were reported, and 59,871 patients (16.4%) abandoned treatment. The prevalence of abandonment was higher in homeless individuals (PR 2.75; 95%CI 2.10-3.61), black race/skin color (PR 1.79; 95%CI 1.46-2.20), HIV/AIDS (PR 1.59; 95%CI 1.30-1.93), alcoholics (PR 1.38; 95%CI 1.14-1.68), illicit drug use (PR 1.85; 95%CI 1.49-2.28), and in individuals who resumed treatment after abandonment (PR 1.91; 95%CI 1.54-2.37).

Conclusion

social vulnerability is associated with the abandonment of tuberculosis treatment.

Key words: tuberculosis; abandonment of tuberculosis treatment; social vulnerability; cross-sectional studies

ABSTRACT

Highlights

The prevalence of abandonment of tuberculosis treatment (ATT) in Brazil between 2014 and 2019 was 16.4%, higher than the 5% recommended by the World Health Organization (WHO). Socioeconomic vulnerability is present among individuals affected by tuberculosis and is associated with ATT. The prevalence of abandonment was higher among homeless individuals, black race/skin color, people living with HIV, alcoholics, illicit drug users, and individuals who resumed treatment after abandonment. Individuals who underwent directly observed treatment (DOT) had the lowest prevalence of ATT.

Key words: tuberculosis; abandonment of tuberculosis treatment; social vulnerability; cross-sectional studies

RESUMO

Síntese dos autores

Por que este estudo foi feito?

A tuberculose é uma das doenças infecto contagiosas que mais mata no mundo. O Brasil ainda não conseguiu atingir as metas estabelecidas pela Organização Mundial da Saúde para o controle e a erradicação da doença. O abandono do tratamento da tuberculose pode contribuir para propagação e a manutenção da cadeia transmissão da doença. Sendo assim, a proposta do estudo foi analisar os fatores associados ao abandono do tratamento da tuberculose para a contribuição na formulação e estratégias de redução do abandono bem como o controle da doença.

O que os pesquisadores fizeram e encontraram?

Realizou-se estudo transversal de indivíduos com diagnóstico de tuberculose no Brasil entre 2014 e 2019, notificados no Sistema de Informação de Agravos de Notificação. Avaliou-se os fatores associados ao abandono da tuberculose. Houve prevalência de 16,4% do abandonaram o tratamento. A prevalência do abandono foi maior em indivíduos em situação de rua, raça/cor da pele preta, pessoas que vivem com HIV, etilistas, uso de drogas ilícitas e os indivíduos que reingressaram o tratamento após abandono. Indivíduos que realizaram o tratamento diretamente observado apresentaram a menor prevalência em abandonar o tratamento da tuberculose.

O que essas descobertas significam?

A vulnerabilidade social e econômica está presente entre os indivíduos acometidos pela tuberculose e está associada ao abandono do tratamento. Portanto, faz-se necessário a implementação de estratégias educativas em saúde, implementação de consultórios de rua com maior enfoque no tratamento da tuberculose, assim como o aumento da oferta do tratamento diretamente observado a fim de reduzir o abandono do tratamento da TB.

Palavras-Chave: tuberculose; pacientes desistentes do tratamento; vulnerabilidade social; estudos transversais

Resumo

Introdução

a tuberculose (TB) é um problema de saúde pública. O Brasil está dentro do grupo de 22 países responsáveis por 90% dos casos de TB do mundo. Altas proporções do abandono do tratamento podem contribuir para esse cenário epidemiológico de difícil controle.

Objetivo

analisar os fatores associados ao abandono do tratamento da tuberculose.

Método

trata-se de um estudo transversal de indivíduos com diagnóstico de tuberculose no Brasil entre 2014 e 2019, notificados no Sistema de Informação de Agravos de Notificação. Utilizou-se regressão de Poisson de variância robusta de acordo com os níveis hierárquicos.

Resultados

foram notificados 508.787 casos, 59.871 (16,4%) abandonaram o tratamento. A prevalência do abandono foi maior em indivíduos em situação de rua (RP 2,75 IC95% 2,10-3,61), raça/cor preta (RP 1,79 IC95% 1,46-2,20), HIV/AIDS (RP 1,59 IC95% 1,30-1,93), etilistas (RP 1,38 IC95% 1,14-1,68), uso de drogas ilícitas (RP 1,85 IC95% 1,49-2,28) e os indivíduos que reingressaram o tratamento após abandono (RP 1,91 IC95% 1,54-2,37).

Conclusão

a vulnerabilidade social está associada ao abandono do tratamento da tuberculose.

Palavras-Chave: tuberculose; pacientes desistentes do tratamento; vulnerabilidade social; estudos transversais

RESUMO

Highlights

A prevalência do abandono do tratamento da tuberculose no Brasil entre o período de 2014 a 2019 foi 16,4%, maior que o recomendado pela Organização Mundial da Saúde de 5%.

Vulnerabilidade socioeconômica está presente entre os indivíduos acometidos pela tuberculose e está associada ao abandono do tratamento.

A prevalência do abandono foi maior em indivíduos em situação de rua, raça/cor da pele preta, pessoas que vivem com HIV, etilistas, uso de drogas ilícitas e os indivíduos que reingressaram o tratamento após abandono.

Indivíduos que realizaram o tratamento diretamente observado apresentaram a menor prevalência em abandonar o tratamento da tuberculose.

Palavras-Chave: tuberculose; pacientes desistentes do tratamento; vulnerabilidade social; estudos transversais

INTRODUCTION

According to the World Health Organization (WHO), tuberculosis (TB) is the most curable infectious disease in the world1. In 2020, TB affected about 9.9 million people worldwide1. Brazil is among the group of 22 countries responsible for 90% of TB cases1-3. In the country, an average of 68,000 new TB cases and around 4,000 deaths are recorded2,3 per year. The proportions of abandonment may contribute to this epidemiological scenario that is difficult to control4,5. In 2020, an abandonment rate of 12.9% was recorded in Brazil, 2.6 times higher than the 5% target set by the WHO1,3.

Identifying the profile of TB patients vulnerable to abandonment of tuberculosis treatment and the factors that can trigger such an outcome becomes an essential tool for establishing actions and strategies involving the management and organization of services, aiming at adherence and control of the disease since abandonment helps in the cycle of spread and contagion of the disease, increased costs, drug resistance, morbidity, and mortality1-6. Given this problem, this study aims to analyze the factors associated with the abandonment of TB treatment.

METHODS

Study design and context

This is a cross-sectional study of individuals diagnosed with TB in Brazil between 2014 and 2019 whose cases had been reported to the Notifiable Diseases Information System (SINAN) of Brazil, in which TB notification is mandatory and its feeding is regularly carried out by all federated entities with information from individuals with suspected or diagnosed diseases and conditions of interest7.

Tuberculosis treatment sensitive to standard drugs lasts at least six months, with a minimum follow-up period which may be extended due to associated diseases or clinical evolution. Thus, individuals are followed longitudinally throughout the treatment, in which periodic information is obtained at different times2,7.

Participants

The study included individuals over 18 years of age whose diagnoses of tuberculosis sensitive to the drugs used in the treatment cases had been reported to SINAN, following national recommendations2.

Individuals with postmortem notification and treatment termination status ignored or blank were excluded, as were those with information on changes in regimen, treatment failure, change in diagnosis, drug-resistant tuberculosis, and death from tuberculosis or other causes.

Variables

The situation at the end of treatment was the dependent variable obtained from the tuberculosis follow-up report at the end of treatment, in which it was reclassified as abandonment of treatment (abandonment and primary abandonment) and cure.

b) Contextual, level II: Geographic region (southeast/northeast/central-west/south/north); Area of residence (urban/rural/peri-urban); Population deprived of liberty (no/yes); Healthcare professional (no/yes); Homeless population (no/yes); Immigrants (no/yes); Beneficiary of income transfer or government aid (no/yes).

c) Associated diseases, level III: Human immunodeficiency virus infection/acquired immunodeficiency syndrome (no/yes); Alcoholism (no/yes); Illicit drug use (no/yes); Smoking (no/yes); Diabetes mellitus (no/yes); Mental disorder (no/yes).

d) Current tuberculosis treatment, level IV: Type of notification (new cases/recurrence/resumption after abandonment/transfer/does not know); Clinical form of tuberculosis (pulmonary/extrapulmonary/pulmonary + extrapulmonary); Sputum smear microscopy results (negative/positive/not performed); Initial culture results (negative/positive/progress/not performed); Chest X-ray (not suggestive of tuberculosis/suggestive of tuberculosis); Directly observed treatment (no/yes).

Data Sources

Data on individuals with tuberculosis were obtained from the Notifiable Diseases Information System (SINAN) provided by the National Tuberculosis Control Program.

Statistical methods

Initially, the absolute and relative frequencies of TB treatment were calculated for each explanatory variable. In the bivariate analysis, Poisson regression of robust variance was used to obtain measures of association between the explanatory variables and the abandonment of TB treatment.

The variables with a p-value <0.20 in the bivariate analysis were introduced into the Poisson regression model of robust variance according to the hierarchical levels proposed by Maciel and Reis-Santos: level I (sociodemographic), level II (contextual), level III (associated diseases/comorbidities) and level IV (current clinical situation related to TB)8. The variables were maintained at the following levels as an adjustment in the model if the p-value was < 0.05. The association of each factor of abandonment of TB treatment is interpreted as adjusted for the variables of the hierarchical levels above it and also of the same level.

The results were expressed by the measure of the association of prevalence ratio (PR) and 95% confidence intervals (95%CI). Statistical analyses were performed using Stata v. 14.0 (StataCorp, CollegeStation, TX, USA).

Ethical procedures

This study was approved by the Human Research Ethics Committee of the Health Sciences Center of the Federal University of Espírito Santo (UFES), under the registration opinion number: 2,088,338, according to Resolution No. 466/2012.

RESULTS

Between 2014 and 2019, 508,787 cases of tuberculosis were reported in individuals over 18 years of age in Brazil. A total of 18,142 (3.5%) cases of death from tuberculosis, 21,366 (4.2%) cases of death from other causes, 31,940 (6.2%) cases of transfers, 3,542 (0.7%) due to change of diagnosis, 5,199 (1.1%) due to drug-resistant tuberculosis, 2,690 (0.5%) due to change of treatment regimen, and 373 (0.1%) due to treatment failure, were excluded from the study. The final population consisted of 364,440 individuals, of whom 59,871 (16.4%) abandoned tuberculosis treatment.

Tables 1 and 2 show the distribution of the frequency of abandonment of tuberculosis treatment by the variables analyzed in the study. In the hierarchical analysis, shown in tables 3 and 4, the prevalence ratio of the abandonment was higher in homeless individuals (PR 2.75; 95% CI 2.10-3.61), resumed treatment after the abandonment (PR 1.91; 95% CI 1.54-2.37), illicit drug use (PR 1.85; 95% CI 1.49-2.28), black race/skin color when compared to white race/color (PR 1.79; 95% CI 1.46-2.20), individuals with HIV/AIDS (PR 1.59; 95% CI 1.30-1.93), and alcoholics (PR 1.38; 95% CI 1.14-1.68). On the other hand, individuals with more than 8 years of schooling (PR 0.53; 95% CI 0.33-0.84), extrapulmonary TB (PR 0.54; 95% CI 0.38-0.77), and those who underwent DOT (PR 0.78; 95%CI 0.66-0.91) had the lowest prevalence ratios.

Table 1 : Distribution of the frequency of abandonment of tuberculosis treatment by demographic and contextual characteristics, Brazil, 2014 to 2019 

Abandonment
Yes No
Variable N (%) N (%)
Sex (n = 364,407)
Female 14,338 (13.09) 95,542 (86.91)
Male 45,475 (17.87) 209,002 (82.13)
Age (n = 364,374)
18-19 years 2,228 (17.24) 10,696 (82.76)
20-39 36,237 (19.67) 147,987 (80.33)
40-59 17,644 (14.84) 101,278 (85.16)
≥ 60 3,756 (7.78) 44,548 (92.22)
Race/skin color (n = 337,599)
White 14,989 (13.12) 99,247 (86.88)
Black 10,260 (21.72) 36,970 (78.28)
Brown (Parda) 29,268 (17.20) 140,887 (82.80)
Asians/Indigenous 728 (12.18) 5,250 (87.82)
Years of study (n = 273,390)
Illiterate 2,401 (15.19) 13,404 (84.81)
0-4 10,306 (17.15) 49,794 (82.85)
5-8 25,157 (17.94) 115,043 (82.06)
> 8 5,116 (8.93) 52,169 (91.07)
Geographic region (n = 364,440)
Southeast 28,820 (16.36) 147,375 (83.64)
South 8,084 (18.33) 36,013 (81.67)
Central-West 2,708 (16.75) 13,456 (83.25)
Northeast 14,054 (15.68) 75,569 (84.32)
North 6,205 (16.18) 32,156 (83.82)
Area of residence (n = 256,954)
Urban 40,635 (17.73) 188,588 (82.27)
Rural 2,645 (10.58) 22,359 (89.42)
Peri-urban 421 (15.44) 2,306 (84.56)
Income transfer benefit (n = 180,092)
Yes 2,172 (14.24) 13,080 (85.76)
No 28,103 (17.05) 136,737 (82.95)
Population deprived of liberty (n = 313,833)
Yes 4,237 (11.20) 33,606 (88.80)
No 47,062 (17.05) 228,928 (82.95)
Healthcare professional (n = 302,062)
Yes 254 (5.71) 4,196 (94.29)
No 49,410 (16.60) 248,202 (83.40)
Homeless population (n = 312,120)
Yes 6,261 (54.39) 5,250 (45.61)
No 44,919 (14.94) 255,690 (85.06)
Immigrants (n = 259,013)
Yes 325 (21.10) 1,215 (78.90)
No 43,254 (16.80) 214,219 (83.20)

Table 2 : Distribution of the frequency of abandonment of tuberculosis treatment by comorbidities and clinical status of tuberculosis treatment. Brazil, 2014 to 2019 

Abandonment
Yes No
Variable N (%) N (%)
HIV / AIDS (n = 326,347)
Yes 9,153 (30.70) 20,660 (69.30)
No 43,311 (14.61) 253,223 (85.39)
Alcoholism (n = 343,115)
Yes 18,196 (27.72) 47,435 (72.28)
No 37,484 (13.51) 240,000 (86.49)
Smoking (n = 311,290)
Yes 17,120 (23.07) 57,101 (76.93)
No 33,390 (14.04) 204,359 (85.96)
Illicit drug use (n = 310,839)
Yes 17,633 (35.53) 31,994 (64.47)
No 32,841 (12.57) 228,371 (87.43)
Diabetes mellitus (n = 341,671)
Yes 2,557 (9.54) 24,223 (90.45)
No 52,540 (16.69) 262,351 (83.31)
Mental disorder (n = 341,016)
Yes 1,707 (20.61) 6,575 (79.39)
No 53,242 (16.00) 279,492 (84.00)
Type of notification (n = 364,440)
New case 38,833 (13.00) 259,919 (87.00)
Recurrence 4,493 (16.68) 22,449 (83.32)
Resumption after abandonment 15,115 (49.99) 15,123 (50.01)
Does not know 155 (22.33) 539 (77.67)
Transfer 1,273 (16.30) 6,536 (83.70)
Clinical form (n = 364,432)
Pulmonary 53,643 (17.14) 259,363 (82.86)
Extrapulmonary 4,633 (10.91) 37,831 (89.09)
Pulmonary + Extrapulmonary 1,594 (17.79) 7,368 (82.21)
Sputum smear results (n = 355,090)
Negative 10,876 (14.94) 61,937 (85.06)
Positive 32,591 (16.59) 163,906 (83.41)
Not Performed 14,977 (17.46) 70,803 (82.54)
Result of the initial culture (n = 364,440)
Negative 4,609 (12.36) 32,677(87.64)
Positive 14,312 (17.30) 68,429 (82.70)
In Progress 1,304 (20.09) 5,186 (79.91)
Not Performed 39,646 (16.66) 198,277 (83.34)
Chest X-ray (n = 348,306)
Not suggestive of TB 2,621 (12.31) 18,678 (87.69)
Suggestive of TB 41,163 (16.57) 207,184 (83.43)
Not Performed 13,486 (17.14) 65,174 (82.86)
DOT (n = 129,037)
Yes 12,725 (13.23) 83,432 (86.77)
No 6,135 (18.66) 26,745 (81.34)

HIV/AIDS: human immunodeficiency virus infection/acquired immunodeficiency syndrome; TB: tuberculosis; DOT: directly observed treatment.

Table 3 : Raw and adjusted prevalence ratio of individuals who abandoned tuberculosis treatment by sociodemographic and contextual characteristics, Brazil, 2014 to 2019 

Raw Analysis Hierarchical Analysis
Variables PR (95%CI) P value* PR (95%CI) P value*
Sociodemographic – Level I
Sex < 0.001 0.078
Female 1.00 1.00
Male 1.36 (1.34-1.38) 1.17 (0.98-1.39)
Age < 0.001 0.001
18-19 years 1.00 1.00
20-39 1.14 (1.09-1.18) 1.04 (0.70-1.56)
40-59 0.86 (0.82-0.89) 0.75 (0.49-1.14)
≥ 60 0.45 (0.42-0.47) 0.38 (0.23-0.65)
Race/skin color < 0.001 < 0.001
White 1.00 1.00
Black 1.65 (1.61-1.69) 1.79 (1.46-2.20)
Brown (Parda) 1.31 (1.28-1.33) 1.12 (0.93-1.34)
Asians/Indigenous 0.92 (0.86-0.99) 0.11 (0.01-0.84)
Years of study < 0.001 < 0.001
Illiterate 1.00 1.00
0-4 1.12 (1.08-1.17) 1.21 (0.80-1.83)
5-8 1.18 (1.13-1.22) 1.21 (0.81-1.82)
> 8 0.58 (0.56-0.61) 0.53 (0.33-0.84)
Contextual – Level II
Geographic Region < 0.001 < 0.001
Southeast 1.00 1.00
South 1.12 (1.09-1.14) 0.67 (0.54-0.81)
Central-West 1.02 (0.98-1.06) 0.33 (0.21-0.54)
Northeast 0.95 (0.94-0.97) 0.69 (0.54-0.89)
North 0.98 (0.96-1.01) 0.39 (0.27-0.58)
Area of residence < 0.001 < 0.001
Urban 1.00 1.00
Rural 0.59 (0.57-0.61) 0.42 (0.26-0.67)
Peri-urban 0.87 (0.79-0.95) 1.03 (0.42-2.53)
Income transfer benefit < 0.001 0.112
Yes 0.83 (0.80-0.86) 0.61 (0.33-1.11)
No 1.00 1.00
Population deprived of liberty < 0.001 0.032
Yes 0.65 (0.63-0.67) 1.35 (1.02-1.78)
No 1.00 1.00
Healthcare Professional < 0.001 0.800
Yes 0.34 (0.30-0.38) 0.84 (0.21-3.21)
No 1.00 1.00
Homeless Population < 0.001 < 0.001
Yes 3.64 (3.57-3.70) 2.75 (2.10-3.61)
No 1.00 1.00
Immigrants < 0.001 0.450
Yes 1.25 (1.14-1.38) 1.85 (0.37-9.18)
No 1.00 1.00
*Poisson regression; PR: prevalence ratio; 95%CI: 95% confidence interval.

Table 4 : Raw and adjusted prevalence ratio of individuals who abandoned tuberculosis treatment by clinical characteristics and comorbidities, Brazil, 2014 to 2019. 

Raw Analysis Hierarchical Analysis
Variables PR (95%CI) P value* PR (95%CI) P value*
Associated diseases – Level III
HIV/AIDS < 0.001 < 0.001
Yes 2.10 (2.06-2.14) 1.59 (1.30-1.93)
No 1.00 1.00
Alcoholism < 0.001 0.001
Yes 2.05 (2.02-2.08) 1.38 (1.14-1.68)
No 1.00 1.00
Smoking < 0.001 0.012
Yes 1.64 (1.61-1.66) 0.72 (0.56-0.93)
No 1.00 1.00
Illicit drug use < 0.001 < 0.001
Yes 2.82 (2.78-2.87) 1.85 (1.49-2.28)
No 1.00 1.00
Diabetes mellitus < 0.001 0.366
Yes 0.57 (0.55-0.59) 0.82 (0.53-1.25)
No 1.00 1.0
Mental disorder < 0.001 0.433
Yes 1.28 (1.23-1.34) 0.82 (0.51-1.33)
No 1.00 1.0
Current tuberculosis treatment - Level IV
Type of Notification < 0.001 < 0.001
New Case 1.00 1.00
Recurrence 1.28 (1.24-1.31) 0.90 (0.65-1.26)
Resumption after abandonment 3.84 (3.78-3.90) 1.91 (1.54-2.37)
Does not know 1.71 (1.49-1.97) 2.57 (0.70-9.43)
Transfer 1.25 (1.19-1.31) 0.82 (0.40-1.70)
Clinical Form < 0.001 < 0.001
Pulmonary 1.00 1.00
Extrapulmonary 0.63(0.61-0.65) 0.54 (0.38-0.77)
Pulmonary + Extrapulmonary 1.03 (0.99-1.08) 0.85 (0.57-1.26)
Sputum smear results < 0.001 0.240
Negative 1.00 1.00
Positive 1.11 (1.08-1.13) 1.09 (0.88-1.33)
Not Performed 1.16 (1.14-1.19) 1.25 (0.96-1.63)
Results of the initial culture < 0.001 0.085
Negative 1.00 1.00
Positive 1.39 (1.35-1.44) 1.40 (1.01-1.95)
In Progress 1.62 (1.53-1.71) 1.57 (0.93-2.64)
Not Performed 1.34 (1.31-1.38) 1.49 (1.09-2.05)
Chest X-ray < 0.001 0.623
Not suggestive of TB 1.00 1.00
Suggestive of TB 1.34 (1.29-1.39) 0.87 (0.58-1.31)
Not Performed 1.39 (1.33-1.44) 0.96 (0.61-1.49)
DOT < 0.001 0.002
Yes 0.70 (0.68-0.72) 0.78 (0.66-0.91)
No 1.00 1.00

*Poisson regression; PR: prevalence ratio; 95% CI: 95% confidence interval; HIV/AIDS: human immunodeficiency virus infection/acquired immunodeficiency syndrome; TB: tuberculosis; DOT: directly observed treatment.

DISCUSSION

The prevalence of the abandonment of tuberculosis treatment in Brazil between 2014 and 2019 was 16.4%, higher than the WHO recommendation of 5%. Self-declared individuals of black race/color, homeless, people living with HIV, alcoholics, illicit drug users, and resumption after the abandonment had the highest prevalence of ATT. On the other hand, individuals who received government assistance, extrapulmonary TB, and who underwent directly observed treatment had the lowest.

The information is generated by several health services, and, although the Ministry of Health standardizes the completion of the information system, the possibility of a classification different from the one recommended cannot be ruled out. However, it is believed that these limitations did not interfere with the results presented, an understanding reinforced by prior evaluations that demonstrated the quality of SINAN, and by the consistency of these results with the findings of the accumulated literature.

It was observed that black individuals had the highest prevalence of abandonment. This occurred because abandonment is linked to the social and economic vulnerability of the black population in Brazil which has less access to employment opportunities, lower income, precarious housing, and difficulty in accessing education and food6,8-10.

Another factor linked to social vulnerability is the abuse of alcohol and other drugs. Precarious living conditions and increased risk of hepatotoxicity due to tuberculosis treatment in this group of patients may aggravate the disease and impair the therapeutic regimen, increasing the chance of abandonment11-13. In addition, alcohol and other drug abuse is a survival characteristic in homeless individuals13,14. Dependence on licit or illicit substances, the presence of other comorbidities such as HIV infection, social marginalization, and low access to public services hinder the process of caring for this population. The results show that the homeless population is especially vulnerable to the abandonment of tuberculosis treatment14-16.

People living with HIV also live in social and economic vulnerability, which influences adherence to TB treatment, as well as the use of antiretrovirals. Abandonment of antiretroviral use was associated with social and economic issues in a systematic review that assessed adherence to treatment in people living with HIV17. Given this, the need to intensify the follow-up of cases of TB-HIV co-infection is reinforced, as well as the incorporation of HIV serological testing in individuals diagnosed with TB18.

The prevalence of abandonment was higher among individuals who resumed treatment. This result shows that even though treatment and access to diagnostic tests are offered, the failure to reduce social and economic vulnerabilities in the daily lives of these individuals makes them more likely to abandon treatment again.

Directly observed treatment had the lowest prevalence of abandonment of TB treatment. Monitoring daily medication intake is a strategy to protect against abandonment. The increased coverage of Family Health Strategy services strengthens the practice of DOT, with a positive impact on longitudinal care centered on individuals with TB19,20.

The lowest prevalence of abandonment of TB treatment was among individuals with extrapulmonary disease. Corroborating our results, studies conducted with SINAN data describe the extrapulmonary form as a factor less likely to abandon treatment21-23. However, we suggest caution in the interpretation of these results, as the extrapulmonary form is more prone to other unfavorable outcomes, such as death and treatment failure24.

As shown, social and economic vulnerability is present among individuals affected by tuberculosis and is associated with the abandonment of tuberculosis treatment. Therefore, it is necessary to implement educational strategies in health, implement street clinics with a greater focus on tuberculosis treatment, and increase the supply of directly observed treatment to reduce abandonment.

REFERENCES

1. World Health Organization - WHO. Global tuberculosis report 2021. Geneva: World Health Organization; 2021. 57 p. [ Links ]

2. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Manual de recomendações para o controle da tuberculose no Brasil. 2. ed. Brasília: Ministério da Saúde; 2019. 364 p. [ Links ]

3. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Epidemiological Report - Tuberculosis 2022. Bol Epidemiol. 2022; especial:1-52. [ Links ]

4. Soeiro VMS, Caldas AJM, Ferreira TF. Abandono do tratamento da tuberculose no Brasil, 2012-2018: tendência e distribuição espaço-temporal. Ciência & saúde coletiva. 2022;27(3):825-836. doi: 10.1590/1413-81232022273.45132020. [ Links ]

5. Ferreira MRL, Bonfim RO, Siqueira TC, Orfão NH. Abandono do tratamento da tuberculose: uma revisão integrativa. Rev Enferm Contemp. 2018;7(1):63-71. doi: 10.17267/2317-3378rec.v7i1.1579. [ Links ]

6. Sousa GJB, Maranhão TA, Leitão TMJS, Souza JT, Moreira TMM, Pereira MLD. Prevalência e fatores associados ao abandono do tratamento da tuberculose. Rev Esc Enferm USP. 2021;55:e03767. doi: 10.1590/S1980-220X2020039203767. [ Links ]

7. Rocha MS, Bartholomay P, Cavalcante MV, Medeiros FC, Codenotti SB, Pelissari DM, et al. Sistema de Informação de Agravos de Notificação (Sinan): principais características da notificação e da análise de dados relacionada à tuberculose. Epidemiol Ser Saúde. 2022;29(1): e2019017. doi: 10.5123/s1679-49742020000100009. [ Links ]

8. Maciel EL, Reis-Santos B. Determinants of tuberculosis in Brazil: from conceptual framework to practical application. Rev Panam Salud Publica [Internet]. 2015 Jul;38(1):28-34. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26506318Links ]

9. Moreira ASR, Kritski AL, Carvalho ACC. Determinantes sociais da saúde e custos catastróficos associados ao diagnóstico e tratamento da tuberculose. J Bras de Pneumol. 2020; 46(5):e20200015. Doi: 10.36416/1806-3756/e20200015. [ Links ]

10. Stopa SR, Malta DC, Monteiro CM, Szwarcwald CL, Goldbaum M, Cesar CLG. Use of and access to health services in Brazil, 2013 National Health Survey. Rev Saúde Pública. 2017;51(Suppl):3s. doi: 10.1590/s1518-8787.2017051000074. [ Links ]

11. Ragan EJ, Kleinman MB, Sweigart B, Gnatienko N, Parry CD, Horsburgh CR, et al. The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis. Int J Tuberc Lung Dis [Internet]. 2020 Jan 1;24(1):73-82. Available from: http://dx.doi.org/10.5588/ijtld.19.0080Links ]

12. Silva DR, Muñoz-Torrico M, Duarte R, Galvão T, Bonini EH, Arbex FF, et al. Fatores de risco para tuberculose: diabetes, tabagismo, uso de álcool e uso de outras drogas. J Bras de Pneumol. 2018;44(2):145-152. doi:10.1590/S1806-37562017000000443. [ Links ]

13. Pelissari DM, Diaz-Quijano FA. Impact of alcohol disorder and the use of illicit drugs on tuberculosis treatment outcomes: a retrospective cohort study. Arch Public Health [Internet]. 2018 Jul 12;76:45. Available from: http://dx.doi.org/10.1186/s13690-018-0287-zLinks ]

14. Hino P, Yamamoto TT, Bastos SH, Beraldo AA, Figueiredo TMRM de, Bertolozzi MR. Tuberculosis in the street population: a systematic review. Rev Esc Enferm USP [Internet]. 2021 Apr 5;55:e03688. Available from: http://dx.doi.org/10.1590/S1980-220X2019039603688Links ]

15. Gioseffi JR, Batista R, Brignol SM. Tuberculose, vulnerabilidades e HIV em pessoas em situação de rua: revisão sistemática. Rev Saúde Pública [Internet]. 2022 May 27;56:43. Available from: https://www.scielo.br/j/rsp/a/dBdWsr9LS6GcfBmCxcJWQ8x/abstract/?lang=ptLinks ]

16. Santos ACE, Brunfentrinker C, Pena LS, Saraiva SS, Boing, AF. Análise e comparação dos resultados do tratamento da tuberculose na população em situação de rua e na população geral do Brasil. J Bras Pneumol. 2021;4(7):e20200178. doi:10.36416/1806-3756/e20200178. [ Links ]

17. Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc [Internet]. 2013 Nov 13;16(3 Suppl 2):18640. Available from: http://dx.doi.org/10.7448/IAS.16.3.18640Links ]

18. Magnabosco GT, Andrade RL de P, Arakawa T, Monroe AA, Villa TCS. Desfecho dos casos de tuberculose em pessoas com HIV: subsídios para intervenção. Acta paul enferm [Internet]. 2019 Oct 10; 32(5):554-63. Available from: https://www.scielo.br/j/ape/a/h463tyNGw5wC3qL8hFHjP8S/?lang=ptLinks ]

19. Zago PTN, Maffacciolli R, Mattioni FC, Dalla-Nora CR, Rocha CMF. Ações de enfermagem promotoras da adesão ao tratamento da tuberculose: revisão de escopo. Rev Esc Enferm USP [Internet]. 2021 Aug 23; 55:e20200300. Available from: https://www.scielo.br/j/reeusp/a/GsJtJhYWQjcy8QwLb35PSkK/abstract/?lang=ptLinks ]

20. Cola JP, Prado TN do, Sales CMM, Maciel ELN. Estratégia Saúde da Família e determinantes para o tratamento diretamente observado da tuberculose no Brasil: estudo transversal com dados do sistema de vigilância, 2014-2016. Epidemiol Serv Saúde [Internet]. 2020 Dec 2;29(5):e2020284. Available from: https://www.scielo.br/j/ress/a/8dPdWgfHB98TtP8sFLhLQHL/abstract/?lang=ptLinks ]

21. Liew SM, Khoo EM, Ho BK, Lee YK, Mimi O, Fazlina MY, et al. Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry. Int J Tuberc Lung Dis [Internet]. 2015 Jul;19(7):764-71. Available from: http://dx.doi.org/10.5588/ijtld.14.0767Links ]

22. Chida N, Ansari Z, Hussain H, Jaswal M, Symes S, Khan AJ, et al. Determinants of Default from Tuberculosis Treatment among Patients with Drug-Susceptible Tuberculosis in Karachi, Pakistan: A Mixed Methods Study. PLoS One [Internet]. 2015 Nov 12;10(11):e0142384. Available from: http://dx.doi.org/10.1371/journal.pone.0142384Links ]

23. Prado TN do, Rajan JV, Miranda AE, Dias EDS, Cosme LB, Possuelo LG, et al. Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis. Braz J Infect Dis [Internet]. 2017 Mar-Apr;21(2):162-70. Available from: http://dx.doi.org/10.1016/j.bjid.2016.11.006Links ]

24. Gomes T, Reis-Santos B, Bertolde A, Johnson JL, Riley LW, Maciel EL. Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model. BMC Infect Dis [Internet]. 2014 Jan 8;14:9. Available from: http://dx.doi.org/10.1186/1471-2334-14-9Links ]

Funding :This study was unfunded.

Received: May 2023; Accepted: December 2023; Published: 2024

Corresponding author: joaopaulocola@gmail.com

Conflicts of interest :

The authors declared there is no conflict of interest.

Creative Commons License this article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.